Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119631) titled 'Study on the efficacy and safety of AP regimen in the chronotherapy of a... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119636) titled 'Clinical Efficacy of Ablation of Slow Conduction and Low-Voltage Myocard... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119639) titled 'Open-label, randomized, phase II clinical study of camrelizumab combined... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119645) titled 'A randomised phase II study of limertinib and bevacizumab versus limerti... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119648) titled 'A single-center, randomized, double-blind, placebo-controlled phase I st... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119651) titled 'A Retrospective Study of AMR in Evaluating Perioperative CMD in Patients... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119655) titled 'Application of Continuous Perinatal CBT Group Intervention Combined with... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119659) titled 'Analysis of Factors Influencing the Failure of Chairside CAD/CAM Onlay R... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119663) titled 'Research on the predictive value of surrogate markers of insulin resista... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119671) titled 'Efficacy and Safety of Camrelizumab plus Rivoceranib and Local Therapy f... Read More